PE and strategics both line up for Healius Agilex

MELBOURNE: The clock is ticking on the sale of Healius’ clinical trials business ... read more

CSL drug revenue faces 65 per cent cut by analysts

SYDNEY: Healthcare giant CSL’s shares are down 0.6 per cent to $114.68 in ... read more

Media company now pays 16.7 per cent dividend

MELBOURNE: A media company has paid an 11 per cent dividend for 22 ... read more

Medtech Ceretas fast-tracks IPO in rush to list on ASX

BRISBANE: University of Queensland spin-out Ceretas could be trading on the local bourse ... read more